Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.

about

Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.

P2860

Q47136990-94EC3443-7708-4325-A358-A7E8B89251E5 Q49795532-CDA6D8EF-ED53-4A5A-B523-56647C29F6D7 Q55401793-DF0D8466-B2C7-4675-95E1-D69A362404F8

P2860

Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.

Item

http://www.wikidata.org/entity/Q42247916

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@en

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@nl

type

Item

label

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@en

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@nl

prefLabel

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@en

Safety and tolerability of aut ...... romal cells in ADPKD patients.

@nl

P1476

Safety and tolerability of aut ...... tromal cells in ADPKD patients

@en

P2093

Hossein Baharvand

http://www.w3.org/2001/XMLSchema#string

Nasser Aghdami

http://www.w3.org/2001/XMLSchema#string

Neda Jaroughi

http://www.w3.org/2001/XMLSchema#string

Reza Moghadasali

http://www.w3.org/2001/XMLSchema#string

Seyedeh Esmat Hosseini

http://www.w3.org/2001/XMLSchema#string

Tina Bolurieh

http://www.w3.org/2001/XMLSchema#string

P2860

Adult stem cells as a tool for kidney regeneration

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease

Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.

Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.

Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.

Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease.

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease

P2888

s13287-017-0557-7

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13287-017-0557-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085558888

http://www.w3.org/2001/XMLSchema#string

P698

28535817

http://www.w3.org/2001/XMLSchema#string

P932

5442691

http://www.w3.org/2001/XMLSchema#string

Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.

about

P2860

P2860

Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932